Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Up 74.7% in February

Oxford Biomedica plc (OTCMKTS:OXBDF) saw a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 33,900 shares, a growth of 74.7% from the January 31st total of 19,400 shares. Based on an average daily volume of 14,600 shares, the days-to-cover ratio is currently 2.3 days.

Oxford Biomedica Stock Performance

OXBDF opened at $4.16 on Tuesday. The company has a debt-to-equity ratio of 1.48, a current ratio of 2.35 and a quick ratio of 2.07. The business’s fifty day simple moving average is $5.05 and its 200-day simple moving average is $5.02. Oxford Biomedica has a 12-month low of $2.17 and a 12-month high of $5.68.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.